C
CVS Health Corporation
CVS
$55.54
-$1.53-2.68%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
C
Hold
5/14/2024Downgrade
CVS Health Corporation (CVS) was downgraded to C- from C on 5/14/2024 due to a decline in the total return index, solvency index and efficiency index. Net income declined 45.6% from $2.05B to $1.11B, debt to equity increased from 0.81 to 0.89, and the quick ratio declined from 0.59 to 0.54.
CVS Health Corporation (CVS) was downgraded to C- from C on 5/14/2024 due to a decline in the total return index, solvency index and efficiency index. Net income declined 45.6% from $2.05B to $1.11B, debt to equity increased from 0.81 to 0.89, and the quick ratio declined from 0.59 to 0.54.
C
Hold
11/3/2023Upgraded
CVS Health Corporation (CVS) was upgraded to C from C- on 11/3/2023 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from $1.48 to $1.75, debt to equity declined from 0.88 to 0.84, and the quick ratio increased from 0.59 to 0.6.
CVS Health Corporation (CVS) was upgraded to C from C- on 11/3/2023 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from $1.48 to $1.75, debt to equity declined from 0.88 to 0.84, and the quick ratio increased from 0.59 to 0.6.
C
Hold
5/22/2023Downgrade
CVS Health Corporation (CVS) was downgraded to C- from C on 5/22/2023 due to a large decline in the growth index, volatility index and total return index. EBIT declined 8.97% from $3.8B to $3.46B, and earnings per share declined from $1.7442 to $1.65.
CVS Health Corporation (CVS) was downgraded to C- from C on 5/22/2023 due to a large decline in the growth index, volatility index and total return index. EBIT declined 8.97% from $3.8B to $3.46B, and earnings per share declined from $1.7442 to $1.65.
C
Hold
2/24/2023Downgrade
CVS Health Corporation (CVS) was downgraded to C from C+ on 2/24/2023 due to a decline in the volatility index and valuation index.
CVS Health Corporation (CVS) was downgraded to C from C+ on 2/24/2023 due to a decline in the volatility index and valuation index.
C
Hold
2/9/2023Upgraded
CVS Health Corporation (CVS) was upgraded to C+ from C on 2/9/2023 due to a large increase in the growth index, valuation index and solvency index. Earnings per share increased from -$2.6 to $1.7429, EBIT increased 6.53% from $3.57B to $3.8B, and total revenue increased 3.17% from $80.96B to $83.52B.
CVS Health Corporation (CVS) was upgraded to C+ from C on 2/9/2023 due to a large increase in the growth index, valuation index and solvency index. Earnings per share increased from -$2.6 to $1.7429, EBIT increased 6.53% from $3.57B to $3.8B, and total revenue increased 3.17% from $80.96B to $83.52B.
C
Hold
1/26/2023Downgrade
CVS Health Corporation (CVS) was downgraded to C from C+ on 1/26/2023 due to a decline in the total return index.
CVS Health Corporation (CVS) was downgraded to C from C+ on 1/26/2023 due to a decline in the total return index.
C
Hold
1/11/2023Upgraded
CVS Health Corporation (CVS) was upgraded to C+ from C on 1/11/2023 due to an increase in the volatility index, valuation index and dividend index.
CVS Health Corporation (CVS) was upgraded to C+ from C on 1/11/2023 due to an increase in the volatility index, valuation index and dividend index.
C
Hold
12/27/2022Downgrade
CVS Health Corporation (CVS) was downgraded to C from C+ on 12/27/2022 due to a decline in the total return index, volatility index and valuation index.
CVS Health Corporation (CVS) was downgraded to C from C+ on 12/27/2022 due to a decline in the total return index, volatility index and valuation index.
C
Hold
11/3/2022Downgrade
CVS Health Corporation (CVS) was downgraded to C+ from B on 11/3/2022 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $2.23 to -$2.6, net income declined 215.76% from $2.95B to -$3.42B, and EBIT declined 15% from $4.2B to $3.57B.
CVS Health Corporation (CVS) was downgraded to C+ from B on 11/3/2022 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $2.23 to -$2.6, net income declined 215.76% from $2.95B to -$3.42B, and EBIT declined 15% from $4.2B to $3.57B.
B
Buy
10/19/2022Downgrade
CVS Health Corporation (CVS) was downgraded to B from B+ on 10/19/2022 due to a major decline in the total return index.
CVS Health Corporation (CVS) was downgraded to B from B+ on 10/19/2022 due to a major decline in the total return index.
B
Buy
10/4/2022Upgraded
CVS Health Corporation (CVS) was upgraded to B+ from B on 10/4/2022 due to a major increase in the total return index, growth index and solvency index. Operating cash flow increased 52.76% from $3.56B to $5.44B, earnings per share increased from $1.74 to $2.23, and the quick ratio increased from 0.54 to 0.62.
CVS Health Corporation (CVS) was upgraded to B+ from B on 10/4/2022 due to a major increase in the total return index, growth index and solvency index. Operating cash flow increased 52.76% from $3.56B to $5.44B, earnings per share increased from $1.74 to $2.23, and the quick ratio increased from 0.54 to 0.62.
B
Buy
5/19/2022Downgrade
CVS Health Corporation (CVS) was downgraded to B from B+ on 5/19/2022 due to a noticeable decline in the total return index and volatility index.
CVS Health Corporation (CVS) was downgraded to B from B+ on 5/19/2022 due to a noticeable decline in the total return index and volatility index.
B
Buy
5/4/2022Upgraded
CVS Health Corporation (CVS) was upgraded to B+ from B on 5/4/2022 due to a noticeable increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.9761 to $1.74, EBIT increased 12.15% from $3.11B to $3.49B, and total revenue increased 0.77% from $76.24B to $76.83B.
CVS Health Corporation (CVS) was upgraded to B+ from B on 5/4/2022 due to a noticeable increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.9761 to $1.74, EBIT increased 12.15% from $3.11B to $3.49B, and total revenue increased 0.77% from $76.24B to $76.83B.
B
Buy
4/28/2022Downgrade
CVS Health Corporation (CVS) was downgraded to B from B+ on 4/28/2022 due to a noticeable decline in the total return index and volatility index.
CVS Health Corporation (CVS) was downgraded to B from B+ on 4/28/2022 due to a noticeable decline in the total return index and volatility index.
B
Buy
4/18/2022Downgrade
CVS Health Corporation (CVS) was downgraded to B+ from A- on 4/18/2022 due to a noticeable decline in the total return index, growth index and solvency index.
CVS Health Corporation (CVS) was downgraded to B+ from A- on 4/18/2022 due to a noticeable decline in the total return index, growth index and solvency index.
A
Buy
3/29/2022Upgraded
CVS Health Corporation (CVS) was upgraded to A- from B+ on 3/29/2022 due to a large increase in the total return index and volatility index.
CVS Health Corporation (CVS) was upgraded to A- from B+ on 3/29/2022 due to a large increase in the total return index and volatility index.
B
Buy
3/15/2022Upgraded
CVS Health Corporation (CVS) was upgraded to B+ from B on 3/15/2022 due to a major increase in the growth index, volatility index and total return index. Total revenue increased 3.66% from $73.55B to $76.24B, and EBIT increased 3.34% from $3.27B to $3.38B.
CVS Health Corporation (CVS) was upgraded to B+ from B on 3/15/2022 due to a major increase in the growth index, volatility index and total return index. Total revenue increased 3.66% from $73.55B to $76.24B, and EBIT increased 3.34% from $3.27B to $3.38B.
B
Buy
12/13/2021Upgraded
CVS Health Corporation (CVS) was upgraded to B from B- on 12/13/2021 due to an increase in the volatility index.
CVS Health Corporation (CVS) was upgraded to B from B- on 12/13/2021 due to an increase in the volatility index.
B
Buy
11/4/2021Downgrade
CVS Health Corporation (CVS) was downgraded to B- from B on 11/4/2021 due to a large decline in the growth index, efficiency index and dividend index. Earnings per share declined from $2.1 to $1.2, net income declined 42.58% from $2.78B to $1.6B, and EBIT declined 14.37% from $4.08B to $3.49B.
CVS Health Corporation (CVS) was downgraded to B- from B on 11/4/2021 due to a large decline in the growth index, efficiency index and dividend index. Earnings per share declined from $2.1 to $1.2, net income declined 42.58% from $2.78B to $1.6B, and EBIT declined 14.37% from $4.08B to $3.49B.
B
Buy
10/22/2021Upgraded
CVS Health Corporation (CVS) was upgraded to B from B- on 10/22/2021 due to an increase in the total return index, growth index and efficiency index. Operating cash flow increased 102.18% from $2.89B to $5.85B, net income increased 25.19% from $2.22B to $2.78B, and earnings per share increased from $1.68 to $2.1.
CVS Health Corporation (CVS) was upgraded to B from B- on 10/22/2021 due to an increase in the total return index, growth index and efficiency index. Operating cash flow increased 102.18% from $2.89B to $5.85B, net income increased 25.19% from $2.22B to $2.78B, and earnings per share increased from $1.68 to $2.1.
B
Buy
4/26/2021Downgrade
CVS Health Corporation (CVS) was downgraded to B- from B on 4/26/2021 due to a decline in the valuation index and dividend index.
CVS Health Corporation (CVS) was downgraded to B- from B on 4/26/2021 due to a decline in the valuation index and dividend index.
B
Buy
4/6/2021Upgraded
CVS Health Corporation (CVS) was upgraded to B from B- on 4/6/2021 due to an increase in the total return index and volatility index.
CVS Health Corporation (CVS) was upgraded to B from B- on 4/6/2021 due to an increase in the total return index and volatility index.
B
Buy
3/9/2021Upgraded
CVS Health Corporation (CVS) was upgraded to B- from C+ on 3/9/2021 due to an increase in the total return index, valuation index and volatility index.
CVS Health Corporation (CVS) was upgraded to B- from C+ on 3/9/2021 due to an increase in the total return index, valuation index and volatility index.
C
Hold
2/22/2021Upgraded
CVS Health Corporation (CVS) was upgraded to C+ from C on 2/22/2021 due to a large increase in the growth index, solvency index and valuation index. Operating cash flow increased 90.34% from $1.87B to $3.57B, debt to equity declined from 0.98 to 0.94, and total revenue increased 3.67% from $66.85B to $69.31B.
CVS Health Corporation (CVS) was upgraded to C+ from C on 2/22/2021 due to a large increase in the growth index, solvency index and valuation index. Operating cash flow increased 90.34% from $1.87B to $3.57B, debt to equity declined from 0.98 to 0.94, and total revenue increased 3.67% from $66.85B to $69.31B.
C
Hold
3/12/2020Downgrade
CVS Health Corporation (CVS) was downgraded to C from C+ on 3/12/2020 due to a decline in the total return index and volatility index.
CVS Health Corporation (CVS) was downgraded to C from C+ on 3/12/2020 due to a decline in the total return index and volatility index.
C
Hold
1/21/2020Upgraded
CVS Health Corporation (CVS) was upgraded to C+ from C on 1/21/2020 due to a noticeable increase in the volatility index and total return index.
CVS Health Corporation (CVS) was upgraded to C+ from C on 1/21/2020 due to a noticeable increase in the volatility index and total return index.
C
Hold
9/30/2019Upgraded
CVS Health Corporation (CVS) was upgraded to C from C- on 9/30/2019 due to an increase in the volatility index and total return index.
CVS Health Corporation (CVS) was upgraded to C from C- on 9/30/2019 due to an increase in the volatility index and total return index.
C
Hold
8/13/2019Upgraded
CVS Health Corporation (CVS) was upgraded to C- from D+ on 8/13/2019 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 174.02% from $1.95B to $5.34B, earnings per share increased from $1.09 to $1.4873, and net income increased 36.24% from $1.42B to $1.94B.
CVS Health Corporation (CVS) was upgraded to C- from D+ on 8/13/2019 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 174.02% from $1.95B to $5.34B, earnings per share increased from $1.09 to $1.4873, and net income increased 36.24% from $1.42B to $1.94B.
D
Sell
3/4/2019Downgrade
CVS Health Corporation (CVS) was downgraded to D+ from C- on 3/4/2019 due to a significant decline in the valuation index, growth index and efficiency index. Net income declined 130.14% from $1.39B to -$419M, and earnings per share declined from $1.36 to -$0.3756.
CVS Health Corporation (CVS) was downgraded to D+ from C- on 3/4/2019 due to a significant decline in the valuation index, growth index and efficiency index. Net income declined 130.14% from $1.39B to -$419M, and earnings per share declined from $1.36 to -$0.3756.
C
Hold
2/28/2019Downgrade
CVS Health Corporation (CVS) was downgraded to C- from C on 2/28/2019 due to a decline in the volatility index and total return index.
CVS Health Corporation (CVS) was downgraded to C- from C on 2/28/2019 due to a decline in the volatility index and total return index.
C
Hold
9/12/2018Upgraded
CVS Health Corporation (CVS) was upgraded to C from C- on 9/12/2018 due to an increase in the solvency index, volatility index and total return index.
CVS Health Corporation (CVS) was upgraded to C from C- on 9/12/2018 due to an increase in the solvency index, volatility index and total return index.
C
Hold
11/21/2017Downgrade
CVS Health Corporation (CVS) was downgraded to C- from C on 11/21/2017 due to a large decline in the total return index, growth index and volatility index.
CVS Health Corporation (CVS) was downgraded to C- from C on 11/21/2017 due to a large decline in the total return index, growth index and volatility index.
C
Hold
11/21/2016Downgrade
CVS Health Corporation (CVS) was downgraded to C from C+ on 11/21/2016 due to a decline in the volatility index and total return index.
CVS Health Corporation (CVS) was downgraded to C from C+ on 11/21/2016 due to a decline in the volatility index and total return index.
C
Hold
11/3/2016Downgrade
CVS Health Corporation (CVS) was downgraded to C+ from B- on 11/3/2016 due to a decline in the volatility index and total return index.
CVS Health Corporation (CVS) was downgraded to C+ from B- on 11/3/2016 due to a decline in the volatility index and total return index.
B
Buy
10/17/2016Downgrade
CVS Health Corporation (CVS) was downgraded to B- from B on 10/17/2016 due to a large decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.61 to 0.54, and debt to equity increased from 0.76 to 0.82.
CVS Health Corporation (CVS) was downgraded to B- from B on 10/17/2016 due to a large decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.61 to 0.54, and debt to equity increased from 0.76 to 0.82.
B
Buy
6/3/2016Downgrade
CVS Health Corporation (CVS) was downgraded to B from B+ on 6/3/2016 due to a decline in the total return index.
CVS Health Corporation (CVS) was downgraded to B from B+ on 6/3/2016 due to a decline in the total return index.
B
Buy
5/19/2016Upgraded
CVS Health Corporation (CVS) was upgraded to B+ from B on 5/19/2016 due to a large increase in the volatility index, total return index and efficiency index.
CVS Health Corporation (CVS) was upgraded to B+ from B on 5/19/2016 due to a large increase in the volatility index, total return index and efficiency index.
B
Buy
3/28/2016Upgraded
CVS Health Corporation (CVS) was upgraded to B from B- on 3/28/2016 due to an increase in the total return index and volatility index.
CVS Health Corporation (CVS) was upgraded to B from B- on 3/28/2016 due to an increase in the total return index and volatility index.
B
Buy
3/11/2016Downgrade
CVS Health Corporation (CVS) was downgraded to B- from B+ on 3/11/2016 due to a substantial decline in the volatility index, total return index and valuation index.
CVS Health Corporation (CVS) was downgraded to B- from B+ on 3/11/2016 due to a substantial decline in the volatility index, total return index and valuation index.
B
Buy
2/18/2016Downgrade
CVS Health Corporation (CVS) was downgraded to B+ from A- on 2/18/2016 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.74 to 0.62, and debt to equity increased from 0.73 to 0.74.
CVS Health Corporation (CVS) was downgraded to B+ from A- on 2/18/2016 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.74 to 0.62, and debt to equity increased from 0.73 to 0.74.
A
Buy
9/29/2015Downgrade
CVS Health Corporation (CVS) was downgraded to A- from A on 9/29/2015 due to a decline in the volatility index and total return index.
CVS Health Corporation (CVS) was downgraded to A- from A on 9/29/2015 due to a decline in the volatility index and total return index.
A
Buy
9/14/2015Upgraded
CVS Health Corporation (CVS) was upgraded to A from A- on 9/14/2015 due to an increase in the valuation index and total return index.
CVS Health Corporation (CVS) was upgraded to A from A- on 9/14/2015 due to an increase in the valuation index and total return index.
A
Buy
8/28/2015Downgrade
CVS Health Corporation (CVS) was downgraded to A- from A on 8/28/2015 due to a decline in the total return index.
CVS Health Corporation (CVS) was downgraded to A- from A on 8/28/2015 due to a decline in the total return index.
A
Buy
8/13/2015Upgraded
CVS Health Corporation (CVS) was upgraded to A from A- on 8/13/2015 due to an increase in the growth index, total return index and efficiency index. EBIT increased 7.08% from $2.13B to $2.28B, earnings per share increased from $1.0701 to $1.12, and net income increased 4.18% from $1.22B to $1.27B.
CVS Health Corporation (CVS) was upgraded to A from A- on 8/13/2015 due to an increase in the growth index, total return index and efficiency index. EBIT increased 7.08% from $2.13B to $2.28B, earnings per share increased from $1.0701 to $1.12, and net income increased 4.18% from $1.22B to $1.27B.
A
Buy
5/26/2015Downgrade
CVS Health Corporation (CVS) was downgraded to A- from A on 5/26/2015 due to a noticeable decline in the growth index, total return index and solvency index. Operating cash flow declined 42.04% from $3.42B to $1.98B, EBIT declined 8.14% from $2.32B to $2.13B, and the quick ratio declined from 0.64 to 0.6.
CVS Health Corporation (CVS) was downgraded to A- from A on 5/26/2015 due to a noticeable decline in the growth index, total return index and solvency index. Operating cash flow declined 42.04% from $3.42B to $1.98B, EBIT declined 8.14% from $2.32B to $2.13B, and the quick ratio declined from 0.64 to 0.6.
A
Buy
4/30/2015Downgrade
CVS Health Corporation (CVS) was downgraded to A from A+ on 4/30/2015 due to a decline in the total return index, valuation index and dividend index.
CVS Health Corporation (CVS) was downgraded to A from A+ on 4/30/2015 due to a decline in the total return index, valuation index and dividend index.
A
Buy
11/19/2014Upgraded
CVS Health Corporation (CVS) was upgraded to A+ from A on 11/19/2014 due to a major increase in the total return index, growth index and efficiency index. Operating cash flow increased 83.39% from $897M to $1.65B, EBIT increased 1.72% from $2.21B to $2.25B, and total revenue increased 1.21% from $34.6B to $35.02B.
CVS Health Corporation (CVS) was upgraded to A+ from A on 11/19/2014 due to a major increase in the total return index, growth index and efficiency index. Operating cash flow increased 83.39% from $897M to $1.65B, EBIT increased 1.72% from $2.21B to $2.25B, and total revenue increased 1.21% from $34.6B to $35.02B.
A
Buy
5/5/2014Upgraded
CVS Caremark Corporation (CVS) was upgraded to A from A- on 5/5/2014 due to an increase in the solvency index, growth index and valuation index. Operating cash flow increased 41.22% from $1.54B to $2.17B.
CVS Caremark Corporation (CVS) was upgraded to A from A- on 5/5/2014 due to an increase in the solvency index, growth index and valuation index. Operating cash flow increased 41.22% from $1.54B to $2.17B.
A
Buy
4/23/2014Downgrade
CVS Caremark Corporation (CVS) was downgraded to A- from A on 4/23/2014 due to a decline in the total return index, valuation index and volatility index.
CVS Caremark Corporation (CVS) was downgraded to A- from A on 4/23/2014 due to a decline in the total return index, valuation index and volatility index.
NYSE
11/08/2024 4:00PM Eastern
Quotes delayed